Story
Shineway Pharmaceutical Declares Special Interim Dividend of RMB 0.85 Per Share

Summary
Shineway Pharmaceutical Group Ltd. (HK: 02877) has announced a special interim dividend of RMB 0.85 per share for the 2026 fiscal year, with the payment scheduled for October 15, 2026.
Shineway Pharmaceutical Group Ltd. (HK: 02877) will distribute a special interim dividend of RMB 0.85 per share for the 2026 fiscal year. The company has scheduled the payment date for October 15, 2026.
Dividend Details
According to a company announcement reported by Zhitong Finance, the board of directors approved the one-time shareholder distribution. This payment is classified as a special interim dividend, meaning it is separate from the company's regular dividend cycle and is being issued before the finalization of full-year financial results.
The key details are as follows:
- Company: Shineway Pharmaceutical Group Ltd.
- Stock Code: 02877
- Dividend Amount: RMB 0.85 per share
- Payment Date: October 15, 2026
AdSignificance for Investors
The declaration of a special dividend often indicates that a company has generated profits or cash flow in excess of its normal operational needs and planned investments. Such distributions are a direct way to return value to shareholders.
By issuing the payment as an interim dividend, the company's management may be signaling confidence in its financial performance and stability during the current fiscal year. The announcement did not specify the record date for shareholders to be eligible for the dividend.
Read next
More on Stocks
UBS Upgrades UK Equities to 'Attractive' on Energy Price Surge and Valuation
The investment bank raised its outlook for UK stocks following a recent pullback, citing strong earnings potential from rising energy prices and setting higher targets for the FTSE 100.

Nikkei 225 Rises 1.52% to Close Week on Sector Strength
Japan's benchmark Nikkei 225 index closed significantly higher on Friday, gaining 1.52% as advances in real estate, banking, and technology shares lifted the market.

Citi Reaffirms Amazon as Top Pick, Sees FTC Lawsuit as Buying Opportunity
Analysts at Citi maintained a Buy rating and a $350 price target on Amazon, advising investors to look past an FTC advertising lawsuit and focus on accelerating AI demand and retail market share gains.

European Stocks End Two-Week Losing Streak on Fed's Inflation Stance
The pan-European Stoxx 600 is poised for its first weekly gain in three, rebounding from multi-month lows after the U.S. Federal Reserve's interest rate hike reassured investors of its commitment to controlling inflation.